Pharmaceutical Dissolution Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Capsule is the fastest growing sector, North America is the largest market

The Global Pharmaceutical Dissolution Testing Services Market is forecast to expand significantly, from USD 761.39 Million in 2025 to USD 1.25 billion by 2031, at an 8.72% CAGR. These services involve outsourced analytical evaluations of drug release rates under simulated physiological conditions, driven by increasing demands for bioequivalence studies and stringent global regulatory quality control mandates. North America's substantial pharmaceutical sales, representing 54.8% of the global total in 2024, underscore the immense volume of products requiring comprehensive quality verification. However, a key impediment to market scalability is the acute scarcity of specialized personnel capable of managing complex method development and validation, creating operational bottlenecks and increasing costs for service providers.

Market Drivers

The market is primarily driven by escalating pharmaceutical R&D investments and an expanding drug pipeline, which significantly increases the volume of compounds requiring solubility and release-rate profiling. In 2024, PhRMA member companies invested approximately $100 billion in R&D, contributing to a high volume of new drug approvals, such as the 50 novel drugs approved by the FDA in 2024, all necessitating extensive dissolution data for quality assurance. Furthermore, the proliferation of generic drugs and stringent bioequivalence requirements are key propellers, as dissolution testing serves as a critical surrogate for in vivo bioequivalence studies, ensuring generic formulations perform identically to innovator products. With generics and biosimilars accounting for 90% of U.S. prescriptions in 2025, there is a vast and continuous demand for comparative dissolution testing to support regulatory applications and maintain post-market batch consistency.

Market Challenges

The primary challenge impeding the Global Pharmaceutical Dissolution Testing Services Market's growth is the acute scarcity of specialized personnel capable of executing complex analytical procedures. Dissolution testing demands highly trained analysts to design, validate, and interpret method development protocols, tasks that cannot be simply automated. This talent gap creates severe operational bottlenecks, limiting production capacity and forcing service providers to extend project timelines or decline new contracts, thereby stalling market expansion. Industry data from the Pistoia Alliance in 2025 indicated that 34% of life sciences organizations identified the lack of skilled personnel as a significant barrier to laboratory operations, highlighting a widening gap between technical requirements and available talent, which also drives up operational costs and diminishes profit margins.

Market Trends

A key trend in the dissolution testing market is the increasing adoption of automated and robotic testing systems, fundamentally altering laboratory workflows to mitigate human error and improve throughput. Service providers are integrating fully automated dissolution apparatuses for tasks from media preparation to sample analysis, a strategic move to optimize efficiency amidst workforce constraints, with 50% of life sciences manufacturers planning increased automation by 2025 according to Rockwell Automation.

Concurrently, the application of Artificial Intelligence (AI) and Machine Learning (ML) for predictive modeling is revolutionizing dissolution data utilization, with laboratories increasingly employing AI algorithms to analyze historical datasets and predict release profiles. This accelerates method development and reduces physical testing requirements, leading to more accurate simulations and faster decision-making. The industry's confidence is evident as 77% of life sciences professionals expect to utilize AI technologies within their laboratories over the next two years, signaling a major paradigm shift towards data-driven testing strategies.

Key Market Players

• Intertek Group Plc
• Avivia BV
• Almac Group
• Agilent Technologies, Inc.
• Catalent, Inc.
• Thermofisher Scientific Inc
• Charles River Laboratories International Inc.
• Cambrex Corp.
• Boston Analytical
• Pace Life Sciences LLC

Report Scope

In this report, the Global Pharmaceutical Dissolution Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Dissolution Testing Services Market, by Services Method:

• In vitro
• In vivo

Pharmaceutical Dissolution Testing Services Market, by Dissolution Apparatus:

• Basket
• Paddle
• Others

Pharmaceutical Dissolution Testing Services Market, by Dosage Form:

• Capsule
• Tablets
• Others

Pharmaceutical Dissolution Testing Services Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Dissolution Testing Services Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.